← FDA Drug Approvals (Drugs@FDA)

PIPERACILLIN AND TAZOBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-10-12

Drug application

FDA Application #

ANDA217409

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIPERACILLIN AND TAZOBACTAM

Generic name

PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM

Active ingredients

PIPERACILLIN,TAZOBACTAM

Dosage form

INJECTION

Route

POWDER,FOR SOLUTION

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Eugia US LLC

First approval

2023-10-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown